Bolt Biotherapeutics, Inc.

NASDAQ:BOLT

0.35 (USD) • At close April 17, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 01.1411.2755.2742.0892.5281.4331.8261.4112.1121.3930.8130.5080.75200000.0670.1640.0650.1210.0150.015
Kosten van de omzet 0015.4330.4580.4970.4621.1891.1861.16718.97318.921.5280.90519.3370.90.80214.8649.549.1666.7877.4356.2386.1656.165
Brutowinst 01.141-14.1584.8161.5922.0660.2440.640.244-16.861-17.527-0.715-0.397-18.585-0.9-0.802-14.864-9.54-9.099-6.623-7.37-6.117-6.15-6.15
Brutowinstmarge 01-11.1040.9130.7620.8170.170.350.173-7.983-12.582-0.879-0.781-24.7140000-135.806-40.384-113.385-50.554-424.138-424.138
Onderzoek- en ontwikkelingskosten 11.72213.78515.43316.07115.82514.95115.64414.62516.84518.97318.9218.38522.48419.33719.70714.12714.8649.549.1666.7877.4356.2386.1656.165
Algemene en administratieve kosten 3.9473.7994.8745.8375.5335.765.6215.6165.6065.4855.5326.3045.0994.9414.0544.2992.0582.8652.0112.1222.1371.30.8730.873
Verkoop- en marketingkosten 000000000000000000000000
Verkoop-, algemene en administratieve kosten 3.9473.7994.8745.8375.5335.765.6215.6165.6065.4855.5326.3045.0994.9414.0544.2992.0582.8652.0112.1222.1371.30.8730.873
Overige kosten 1.24703.5654.67500000000000-6.084-14.1252.38000000
Bedrijfskosten 16.91617.58419.8521.90821.35820.71121.26520.24122.45124.45824.45224.68927.58324.27823.76118.42616.92212.40511.1778.9099.5721.2990.8940.894
Bedrijfsresultaat -16.916-16.443-22.597-17.092-19.766-18.183-19.832-18.415-21.04-22.346-23.059-23.876-27.075-23.526-23.761-18.426-16.922-12.405-11.11-8.745-9.507-7.417-7.023-7.023
Bedrijfsresultaat ratio 0-14.411-17.723-3.241-9.462-7.193-13.839-10.085-14.911-10.58-16.553-29.368-53.297-31.2850000-165.821-53.323-146.262-61.298-484.31-484.31
Totaal overige inkomsten en kosten netto 0.981.2671.4026.2811.8631.9261.7751.4351.0430.5870.3950.198-0.0820.1310.176-6.028-14.1132.4040.0510.1120.1450.2330.0520.052
Inkomen voor belasting -15.936-15.176-21.195-10.811-17.903-16.257-18.057-16.98-19.997-21.759-22.664-23.678-27.157-23.395-23.585-24.454-31.035-10.001-11.059-8.633-9.362-7.184-6.971-6.971
Inkomen voor belasting ratio 0-13.301-16.624-2.05-8.57-6.431-12.601-9.299-14.172-10.303-16.27-29.124-53.459-31.110000-165.06-52.64-144.031-59.372-480.724-480.724
Belastingkosten 0000.4151.897-0.4620.336-1.435-1.0430-0.395-0.198-0.361-0.761-0.6446.02813.892-2.404000000
Nettowinst -15.936-15.176-21.195-10.811-17.903-16.257-18.057-15.545-18.954-21.759-22.269-23.48-27.157-23.395-23.585-24.454-31.035-10.001-11.059-8.633-9.362-7.184-6.971-6.971
Nettowinstmarge 0-13.301-16.624-2.05-8.57-6.431-12.601-8.513-13.433-10.303-15.986-28.881-53.459-31.110000-165.06-52.64-144.031-59.372-480.724-480.724
WPA (Winst Per Aandeel) -0.42-0.4-0.56-0.28-0.47-0.43-0.48-0.41-0.5-0.58-0.6-0.63-0.73-0.63-0.64-1.14-0.97-0.71-0.79-0.62-0.67-3.54-3.59-3.59
Verwaterde WPA -0.42-0.4-0.56-0.28-0.47-0.43-0.48-0.41-0.5-0.58-0.6-0.63-0.73-0.63-0.64-1.14-0.97-0.71-0.79-0.62-0.67-3.54-3.59-3.59
EBITDA -15.243-16.003-18.575-16.634-19.299-17.721-19.374-17.948-20.578-21.907-22.651-23.519-26.714-23.222-23.505-18.154-16.701-12.226-11-8.644-9.411-7.332-6.946-6.946
EBITDA ratio 0-14.025-14.569-3.154-9.238-7.01-13.52-9.829-14.584-10.373-16.261-28.929-52.587-30.880000-164.179-52.707-144.785-60.595-479-479